Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 12, 2026 16:30 ET | Source: Profound Medical Corp.

Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th – Conference Call to Follow

TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative...
February 12, 2026 08:30 ET | Source: Profound Medical Corp.

Profound Medical Honored with INOVAIT’s 2025–2026 Mount Logan Award Recognizing the TULSA Procedure™ for Prostate Disease

TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage innovator in interventional MRI (“iMRI”) procedures, is...
February 12, 2026 07:30 ET | Source: EDAP TMS S.A.

EDAP Announces Appointment of David Horn to Board of Directors

EDAP Announces Appointment of David Horn to Board of Directors AUSTIN, Texas, February 12, 2026 – EDAP TMS S.A. (Nasdaq: EDAP) (“the Company” or “EDAP”), a global leader in therapeutic...
February 10, 2026 06:57 ET | Source: Research and Markets

AI in Oncology Research and Long-term Forecasts Report 2026-2040: Siemens Healthineers and GE Healthcare Lead, While NVIDIA, IBM, Tempus, PathAI, and Emerging Specialists Expand Use Cases

Dublin, Feb. 10, 2026 (GLOBE NEWSWIRE) -- The "AI in Oncology Market, till 2040: Distribution by Type of Cancer, Type of End User, and Geographical Regions: Industry Trends and Global Forecasts"...
February 04, 2026 01:30 ET | Source: Curium

Curium Group, PeptiDream and PDRadiopharma Enroll First Patient to Registrational Clinical Trial of Lu-PSMA-I&T for Prostate Cancer in Japan

A Registrational Phase 2 clinical trial has been initiated in Japan for patients with PSMA-positive metastatic castration-resistant prostate cancer (mCRPC). BOSTON, Feb. 04, 2026 (GLOBE NEWSWIRE)...
February 02, 2026 10:02 ET | Source: Urology Care Foundation

Keep Life Flowing Smoothly This National Cancer Prevention Month: Your Guide to Taking Action

BALTIMORE, Feb. 02, 2026 (GLOBE NEWSWIRE) -- February is National Cancer Prevention Month and to help people keep life flowing smoothly, the Urology Care Foundation (UCF), the official foundation of...
January 26, 2026 05:00 ET | Source: NUCLIDIUM AG

NUCLIDIUM Announces Issuance of New U.S. Patent Covering its 61Cu-based Radiodiagnostic Program for PSMA-positive Prostate Cancer

Patent for composition of matter and methods of use of high-radiopure diagnostic ⁶¹Cu-NU101 and combination use with therapeutic pair ⁶⁷Cu-NU101
January 12, 2026 07:30 ET | Source: EDAP TMS S.A.

EDAP Announces Preliminary Record Fourth Quarter and Full Year 2025 HIFU Revenue; Issues 2026 Revenue Guidance

EDAP Announces Preliminary Record Fourth Quarter and Full Year 2025 HIFU Revenue; Issues 2026 Revenue Guidance 36% to 38% Annual YoY HIFU Revenue Growth, Record Performance Driven by Increased Focal...
January 07, 2026 13:28 ET | Source: Koelis

Koelis Announces Designated CPT I Codes for Fusion Biopsy and Transperineal Biopsy in Prostate Cancer Diagnosis

Koelis announces final ruling of designated CPT I codes for fusion biopsy and transperineal biopsy in prostate cancer diagnosis.
December 23, 2025 02:00 ET | Source: Curium

Curium Announces First Commercial Doses of PYLCLARI® for Patients with Prostate Cancer in Poland

PYLCLARI® provides solutions to a wider patient group across Poland where there is high demand and unmet need PARIS, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine,...